Skip to content
Menu

Cascadian Therapeutics, Inc. CASC

Full chart Compare
Set alert

Price alert · CASC

All alert types

No live quote for CASC yet.

 

No chart data for this range yet.
Volume
2.00K
Open
10.00
Previous close
10.02

Fundamental scorecard

7 of 25 checks passed on CASC’s reported financials

ValueGrowthProfitabilityHealthDividend

7of 25 checks passed

  • Value 1 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Dec 31, 2017; valued at the market value on the latest filing.

Financials — quick view

All financials
CASC Revenue — quarterly 0
CASC Net income — quarterly -16.76M
CASC EPS — quarterly -0.34

Upgrades / downgrades

CASC analyst upgrades and downgrades
DateFirmActionFromTo
Sep 6, 2017Barclaysinit—Underweight
Apr 20, 2017BTIG Researchinit—Buy
Feb 21, 2012Global Hunter Securitiesdown—Accumulate

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on CASC — it syncs with the Stock Master app.